Testosterone Explained (Low T, Muscle Growth, Aging & TRT) | Dr. Ben House

Episode Overview

• Professor and human performance scientist Dr. Andy Galpin and Dr. Ben House (PhD in Nutritional Sciences with ~20 years of experience consulting for NBA, NFL, MLB, and collegiate athletes) deconstruct the science of testosterone, separating clinical evidence from pervasive internet myths.
• The conversation progresses from the biochemistry of hormone transport and massive laboratory measurement errors to the true statistical relationship between natural testosterone, muscle hypertrophy, and sexual function.
• They examine the primary root causes of low testosterone—highlighting the contrast between obesity-driven suppression and starvation/dieting-induced suppression—while dismantling the myth of inevitable age-related "andropause."
• Finally, the episode provides a rigorous analysis of Testosterone Replacement Therapy (TRT), detailing widespread diagnostic malpractice, pharmacology, and severe cardiovascular risks when supraphysiological protocols are mismanaged.

Key Concepts

• Speaker Disclosures and Commercial Ties: Dr. Andy Galpin is an official partner with Momentous (since 2023), works with Springbok Analytics (MRI), and shares promotional ties with Momentous (up to 35% off first order with code GALPIN), David Protein bars, Eight Sleep (up to $350 off with code PERFORM), and LMNT (free sample pack with purchase). Dr. Ben House also works with Springbok Analytics (MRI) and conducts blood and laboratory analyses for private clients.
• Testosterone Concentration and Measurement Error: Measuring hormones requires finding microscopic quantities. Normally, the human bloodstream holds ~5 grams of blood glucose (7 to 9 grams in diabetes). In an average backyard swimming pool, hematocrit would fill half the pool and glucose would equal 150 lbs, whereas male Total Testosterone equals half a paperclip to a couple paperclips of dissolved salt, and Free Testosterone equals just 5 milligrams of salt. Because concentrations are so tiny, Total Testosterone assays carry a ~6% analytical error, and Free Testosterone assays carry a 12% to 15% intra-assay error. Standard estradiol immunoassays have a 20% to 40% error rate (cross-reacting with other estrogens to give fictitiously high readings in men), and even ultrasensitive estradiol via LC-MS carries a 15% to 18% error rate.
• Normal Ranges and Daily Biological Fluctuations: In males, the low-end threshold for Total Testosterone is debated between 264 and 300 ng/dL (Bhasin's harmonized reference range established 264 ng/dL as the 2.5th percentile and ~306 ng/dL, rounded to 300, as the 5th percentile), while natural high-end levels can exceed 1,200 ng/dL; the average 40-to-50-year-old male sits around 550 ng/dL, and the Free Testosterone low-end threshold is ~66 pg/mL. Female Total Testosterone is roughly 10% of male levels (~20 to 60 ng/dL, with a debated low end around 20 ng/dL). Diver et al. (2003) showed that testosterone peaks during slow-wave/REM sleep and drops 30% to 40% (up to 43% from peak to nadir) by evening. Furthermore, eating before a blood draw drops testosterone by 19% (which skewed the non-fasting, 10-hour-window UK Biobank averages down into the 300s). Stacking wake times, plasma volume/hydration shifts, and lab error easily creates a 20% to 30% variance (e.g., a 120 ng/dL swing on a 600 ng/dL baseline).
• Hormone Binding Kinetics and the SHBG Misconception: Only ~2% (1–3%) of circulating testosterone is Free Testosterone. Roughly 45% to 55% (~48%) is tightly bound to Sex Hormone-Binding Globulin (SHBG)—though the protein megalin can endocytose the SHBG-testosterone complex into kidney and reproductive tract cells—and the remaining ~50% to 52% is weakly bound to albumin, which is fully bioavailable to tissues because binding/dissociation occurs on millisecond timelines. Standard lab reference ranges for SHBG are fictitiously low because they are built on metabolically deranged populations where hepatic steatosis (liver fat) drives SHBG down to 20–30 nmol/L. In healthy, insulin-sensitive athletes, SHBG naturally scales from 40 to 60 nmol/L (averaging 45 nmol/L in House and Tommy Wood's convenience sample of jacked athletes). Clinics routinely misdiagnose healthy men who have a 650 ng/dL Total Testosterone and an SHBG of 53 nmol/L as having "borderline calculated Free Testosterone," putting them on TRT when they are simply lean or under-eating.
• Diagnostic Failures and True Prevalence of Hypogonadism: Roughly 42% of men who test low on an initial draw are not hypogonadal on a repeat draw, yet in certain datasets, only 4% of men prescribed TRT received the required two diagnostic blood draws beforehand (96% skipped protocol). In a random fasting morning sample of 100 US men, ~25% have Total Testosterone <300 ng/dL (40.2% in obese men with BMI >30, vs. 11% in normal-weight men), but only 5% to 6% of all-comers have both low levels and clinical symptoms. In normal-weight men, only 0.9% have both low testosterone and symptoms. Per House and Wood's NHANES analysis, among metabolically healthy men under age 50 (waist-to-height ratio <0.5, normal HbA1c, triglycerides, HDL, and blood pressure), the prevalence of Total Testosterone <300 ng/dL is just 0.9% to 2%.
• Natural Testosterone Does Not Drive Muscle Hypertrophy: While Benito et al.'s meta-analysis (~150 studies) shows the average untrained person gains ~1.5 kg (~3 lbs) of lean body mass over 10 to 12 weeks of lifting, natural testosterone variations do not dictate who grows. Across 5 to 6 studies (including Mike Roberts' work with Haun/Mobley et al.), within the normal eugonadal range (300 to 1,000+ ng/dL), there is a flatline zero correlation between Total or Free Testosterone and muscle hypertrophy. In Mobley/Haun, a subject with a natural 1,900 ng/dL Total Testosterone was middle-of-the-pack for muscle growth, while a subject at 500 ng/dL gained 8 kg of muscle in 12 weeks; combining all hormones in a regression model explains no more than 25% of hypertrophy variance. In their pro-athlete databases, Galpin and House see 21-to-25-year-olds naturally at 1,050 to 1,150 ng/dL (SHBG in the 50s) alongside equally dominant pros with Fat-Free Mass Indexes (FFMI) of 25 to 27 (the natural limit gold standard) cruising at 400 to 500 ng/dL.
• Chemical Castration, Recomp Paradoxes, and Supraphysiological Dosing: Even at extreme lows, muscle grows if mechanical tension is present. In Kvorning et al. (2006) and Gharahdaghi et al. (2022), young men chemically castrated with goserelin (Zoladex, a GnRH agonist that ablates pulsatile LH release), dropping Total Testosterone from ~600 ng/dL to ~30 ng/dL for 8–10 weeks of lifting (within a ~20-week study), had zero/one dropout and still gained 1.2 kg of lean mass vs. 2.1 kg in placebo (a 43% to 73% blunting, with equal strength gains in some measures). Furthermore, in Longland et al. (2016), overweight men (~23% body fat, BMI 29) on a 4-week severe deficit (~33 kcal/kg LBM, 12,000 steps/day, 6 workouts/week) evaluated via a 4-compartment model lost 11 lbs of fat (dropping to 19% body fat) and gained 2 to 3 lbs of muscle while their Total Testosterone crashed from 500 to 110 ng/dL and SHBG rose 30%. Conversely, in Vidić et al., men on a 10-week moderate weight-loss keto/high-fat resistance program saw Total Testosterone rise ~20% (from 600 to 800 ng/dL) yet gained zero muscle and zero strength. Only when taking exogenous supraphysiological testosterone—as in Bhasin et al. (1996) using 600 mg/week to yield ~10 kg of lean mass in 20 weeks—does a dose-response relationship emerge (House notes his own stats are 180 lbs at 12% body fat, estimating exogenous gear would easily push him to 190 lbs at 10% body fat).
• Libido and Sexual Function Thresholds: Primate fieldwork by Robert Sapolsky and animal castration models reveal that castrated males still have sex (though less frequently), and restoring just 10% of baseline testosterone restores 100% of sexual behavior. In humans, Wu et al. (2010) and Finkelstein's graded-exposure trials demonstrate that sexual desire, libido, and erectile function only hit a statistical inflection point of decline when Total Testosterone drops below 200 to 300 ng/dL (reaching significance at 100 ng/dL in Finkelstein). Additionally, estradiol is critical for male libido, bone health, and brain tissue.
• Obesity vs. Caloric Deficit as Primary Drivers: Mendelian randomization confirms that body composition drives testosterone far more than eugonadal testosterone drives body composition. Obesity is the #1 cause of male hypogonadism (lowering SHBG and causing central leptin resistance, which downregulates hypothalamic kisspeptin/GnRH; in women, obesity causes a hyperandrogenic state like PCOS), and bariatric surgery increases Total Testosterone by an average of 207 ng/dL. Conversely, energy deficits suppress testosterone via falling leptin:
• Military & Longevity Deficit Data: 7-day military operational studies (Hamarsland, Friedl, Henning/Nindl) show multi-stressor caloric deficits tank leptin, drop Total Testosterone to 60–80 ng/dL, and spike SHBG from 20 to 50 nmol/L (exogenous LH/HCG fails to fix it because suppression is central, but 1 week of refeeding restores testosterone and drops SHBG to 20 nmol/L). Similarly, Cangemi et al. (2010) showed lean individuals living at a chronic 10% to 20% caloric deficit had low IGF-1, high SHBG, and lower Total Testosterone (300 to 400 ng/dL).
• Extreme Leanness & Massive Weight Loss: When House dieted to 3% body fat on InBody (~5–6% on DEXA), he experienced hot flashes from low estrogen, a leptin of 0.6, and Total Testosterone in the 300–400s (a 2-week calorie refeed without weight gain pushed his SHBG into the 60s and restored his levels). A natural bodybuilder client who dieted to <5% body fat (190 lbs, FFMI ~26) crashed his Total Testosterone to 26 ng/dL with unmeasurable Free T3, but refeeding to 12% body fat restored his Total Testosterone to 650 ng/dL with SHBG at 25–35 nmol/L (Mitchell et al. also showed natural bodybuilders recovering hormones around ~8% on DEXA). Among three of House's clients who lost half their body weight (300 to 150 lbs, or 330 to 180 lbs), one had a Total Testosterone of 850 ng/dL, while two were tanked in the 200s (one with anemia) despite being >15% body fat because the brain perceives massive relative drops from peak leptin as starvation.
• The Myth of Age-Related Decline ("Andropause"): While Santi et al. (2025) indicates a secular decline in population testosterone over the last 50 years, unadjusted longitudinal aging studies showing a 1% to 2% annual drop after age 30 are confounded by accumulating sickness and fat. Carnegie/Camacho et al. (2023) found that filtering out men with comorbidities cut the annual decline in half (from 1.5% to a non-significant 0.8%). Shi et al. (2013) showed that men with zero components of metabolic syndrome (~23–25% of the population) experienced zero decline in testosterone with age, and pooled trials by Marriott et al. (2023) and Kelsey et al. (2014) confirmed age is not an independent predictor of testosterone decline until after age 70 (likely due to Leydig cell oxidative stress). Galpin's database even includes 75+ year-old men who eat fast food, take no peptides or vitamins, and naturally maintain Total Testosterone at 750 ng/dL.
• Sleep, Lifestyle, and Structural Suppressors: Leproult et al. (2011) showed 8 days of sleep restriction (5 hours/night) reduced daytime testosterone area-under-the-curve by 15%. Marriage, pair-bonding, and co-sleeping/having children are associated with a ~10% drop. Other clinical culprits include micronutrient deficiencies (zinc, magnesium, copper), medications (SSRIs, opioids), pituitary adenomas, constrictive bicycle seats in high-volume cyclists/triathletes, and varicoceles (enlarged testicular veins aggravated by Valsalva maneuvers, present in up to 80–90% of Olympic lifters in some studies; surgical repair can increase testosterone by 150 to 200 ng/dL).
• TRT Pharmacology and Cardiovascular Risks: Leydig cells naturally produce 6 to 10 mg of testosterone daily (~43 to 60 mg/week). Because testosterone cypionate is ~70% testosterone by weight, a standard 100 mg/week prescription delivers ~70 mg of hormone—already supraphysiological. Exogenous testosterone shuts down endogenous LH/FSH, causing testicular atrophy (unless co-administered with HCG), and stopping cold turkey risks severe withdrawal, clinical psychosis, and suicidality. High testosterone upregulates erythropoietin (EPO), driving red blood cell production (erythrocytosis) and blood viscosity; combined with training-induced left ventricular hypertrophy, this places severe back-pressure on the heart. While the TRAVERSE trial prompted removal of the FDA cardiovascular black-box warning, it only used transdermal AndroGel to bring diagnosed hypogonadal men to mid-normal levels (finding no increase in major adverse cardiac events vs. placebo)—it did not study injectable "TRT+" at 1,000 to 1,500 ng/dL. Conversely, a 2026 study ("Kearns 2026") found that one-third of men prescribed TRT had no hypogonadism diagnosis, and this group suffered a 51% increased risk of major cardiac events.
• Important Caveats, Hedges, and Weak Evidence:
• Personal Deltas & Twin Thought Experiment: House holds a "loosely held belief" that an individual's personal drop (e.g., 800 to 500 ng/dL) might still matter despite null population data, and notes we don't know if peak teenage testosterone dictates peak bone mass. Asked by Galpin if an identical twin pharmacologically clamped at 350 ng/dL via Zoladex would build the exact same muscle as his twin at 750 ng/dL, House admits, "I don't know," betting "yes" only if purely pharmacological, since real-world 400-point gaps imply underlying confounders like head trauma, sleep apnea, or illness.
• Data Limitations (Assays, Aging, Sleep, Overtraining, Leanness, Longevity, TRT+): Secular 50-year declines may be partly confounded by assay changes between the 1970s and 2020s, and NHANES lacks enough metabolically healthy 70- and 80-year-olds for definitive statistical claims in that bracket. Smoking weirdly appears to slightly increase testosterone and SHBG (possibly via weight regulation), while marijuana data is mixed/ambivalent. We have zero long-term controlled data on chronic sleep restriction (years of 4–5 hours/night) or on "Instagram bodybuilders" maintaining 5% body fat for two years straight. Evidence that overtraining lowers testosterone independent of caloric deficit and sleep loss is weak (6–8 week high-volume studies in calorie-replete lifters show no change). While chronic 10–20% caloric restriction extends lifespan in mealworms, it tanks human testosterone and IGF-1, leaving human longevity math unknown. Finally, because we ethically cannot run long-term RCTs on healthy men running supraphysiological "TRT+" (1,200–1,500 ng/dL), we simply do not know if it is harmless when managed or lethal.

Quotes

• At 0:00:26 - "Really, if testosterone is ever your first line, just from a low testosterone draw, if testosterone is the answer there, I'm walking to the door. Like, it's not as simple as low testosterone, testosterone. There's a hundred and twenty things that can cause low testosterone. You should not be, you should be asking like, why is this low?" - Dr. Ben House explaining why a low blood draw should trigger root-cause investigation rather than an immediate prescription.
• At 0:02:35 - "I think the internet thinks it's more important than it probably is. Um, that's not to say that it's not important and that it doesn't change, that it can't change physiology, but I think we give it, inside of the normal range, we give it a lot more credit than it's probably due." - Dr. Ben House framing the central thesis on physiological vs. supraphysiological hormone levels.
• At 0:05:02 - "Testosterone upregulates EPO, which is going to tell your body to make more red blood cells. So if you have more red blood cells, then your blood will get more viscous, so you're, now you're not pumping blood, you're pumping oil." - Dr. Ben House illustrating the cardiovascular danger of redlining testosterone and elevating hematocrit.
• At 0:07:31 - "To have an idea of how much testosterone is in your blood, if you take the average backyard pool, you're looking at, like, a male is like half a paperclip. So take half a paperclip or a paperclip, whatever, it doesn't matter... of salt and dissolve it in your pool, and then we're going to go find that with science." - Dr. Ben House using an analogy to explain why hormone assays are prone to measurement error.
• At 0:13:09 - "You have this globular protein, and albumin is the other carrier, and these are globular proteins and they're grabbing testosterone, right? And it's how strong the grip is. Sex hormone-binding globulin has a much stronger grip than albumin, uh, but it still can be unlocked, like it can be released." - Dr. Ben House clarifying how carrier proteins transport and release bioavailable testosterone in the bloodstream.
• At 0:18:05 - "There's intra-assay variability. So if I grab your blood, let's just say it's the same vial, um, and I just throw it through the same process. This is, if we just run the same lab, everything, you'll get 12 to 15 percent error intra-assay." - Dr. Ben House detailing the analytical error rate of Free Testosterone testing.
• At 0:19:32 - "I only want to see free testosterone through equilibrium dialysis. Like, that's the gold standard. Like, you start, I'm not really interested in calculated free testosterone... And the same thing with testosterone, you don't, these aren't, yeah, these exist, like you wouldn't want an immunoassay, uh, you want that to be LC-MS or mass spec." - Dr. Ben House specifying the exact laboratory methodologies required for accurate hormone panels.
• At 0:24:54 - "It's some crazy number, like 42% of people on repeat draws are not hypogonadal. Like, the numbers are so bad that, like, they almost, like, can't be real, in that 4% of people who get on TRT in certain scenarios have gotten two draws." - Dr. Ben House highlighting the massive rate of false-positive single draws and clinical non-compliance with diagnostic guidelines.
• At 0:29:59 - "Because sex hormone-binding globulin, the lab range is built off a metabolically deranged population, so it's fictitiously low. So now, all of a sudden, your free testosterone is borderline, that person gets put on—that person has no business being, like, I'm, I'm bullish in, like, 650 plus a borderline high sex hormone-binding globulin, no, no, no, no, no." - Dr. Ben House explaining how healthy, insulin-sensitive men get wrongly placed on TRT due to skewed SHBG reference ranges.
• At 0:35:10 - "You definitely don't want to have a hematocrit above 52, you definitely do not want to have a hematocrit of 54 or higher. Like, that's, you need—you are playing with fire from a lot of different angles." - Dr. Ben House establishing hard safety ceilings for red blood cell volume on TRT.
• At 0:38:20 - "I would bet that you will feel worse at low estrogen and high testosterone than you would at low-range testosterone. Because estrogen is really, really important for sexual desire, it's really, really important for bone, it's, it's really, really important just for your brain and a ton of different tissues." - Dr. Ben House emphasizing the vital physiological role of estradiol in men.
• At 0:45:12 - "And then they go cold turkey off. You rip testosterone away, like, look at the literature: psychosis, like, this is, like, you get suicidal risk. Like, in the literature, you can find that. Like, this is not, so like, this is not something that you want to do." - Dr. Ben House warning against abruptly discontinuing exogenous testosterone after endogenous production is shut down.
• At 0:53:36 - "They had these people resistance train, and in the—as low as you can imagine testosterone being for a male, and they still gained lean body mass. It was blunted compared to the placebo, like 43 to 73 percent, but they still gained muscle on castrate levels of testosterone." - Dr. Ben House discussing the Kvorning and Gharahdaghi chemical castration studies using Zoladex.
• At 0:56:36 - "Their testosterone went from 500 to 110. One of the best recomp studies that we have, sex hormone-binding globulin went up 30%, and they had—they almost did it to themselves, right? They weren't at castrate levels, but they were tanked, absolutely tanked." - Dr. Ben House describing Longland et al. (2016), where subjects lost 11 lbs of fat and gained 2–3 lbs of muscle despite crashing their testosterone.
• At 1:01:31 - "All of them to date, every study to date has not shown a relationship between total testosterone and the amount of muscle that people gain. Like, they're all null." - Dr. Ben House summarizing the research on natural eugonadal testosterone levels and resistance training hypertrophy.
• At 1:15:05 - "Obesity is the number one driver of hypogonadism in males. And when obese or overweight males lose weight, they lose adipose tissue, invariably testosterone goes up, and sex hormone-binding globulin goes up as well." - Dr. Ben House identifying excess body fat as the primary reversible cause of low testosterone in the general population.
• At 1:24:20 - "I'm quite confident, this is from MR, Mendelian randomization, that body comp affects testosterone way, way, way, way, way, way more inside of the eugonadal range than testosterone affects body composition." - Dr. Ben House reversing the common assumption about causality between hormones and physique.
• At 1:28:13 - "If you're very, very healthy and under 50, under 50 years old, and your, your waist circumference is half of, like, your, your waist circumference can't be higher than half of your height... if your blood glucose control is quite good, if your triglycerides are solid, and your HDL is solid, and your blood pressure is regulated, there's probably a less than 1% chance that you have low, below 300, total testosterone." - Dr. Ben House sharing findings from his NHANES data analysis with Dr. Tommy Wood.
• At 1:35:01 - "The largest study that we have, Marriott 2023, I believe, like crazy amount of people, they looked at like what predicted the decrease in testosterone, and age wasn't a factor until after 70." - Dr. Ben House debunking the belief that male testosterone inevitably declines by 1–2% per year starting at age 30.
• At 2:36:54 - "What they found was there was a 51% increased risk of major cardiac events in the individuals who did not have any diagnosis of hypogonadism and went on TRT. There's a ton of confounders there, but I think that that population that they've identified—and it wasn't a small number, unfortunately, it was one-third of people who got testosterone—that population had an increased risk." - Dr. Ben House citing a 2026 study on the cardiovascular dangers of prescribing TRT to eugonadal men.

Takeaways

• Establish Early Longitudinal Baselines: Measure Total Testosterone, Free Testosterone, and SHBG in your late teens or early twenties so you can track your personal delta over decades rather than relying solely on population bell curves.
• Follow Strict Diagnostic Blood Draw Protocols: Never diagnose hypogonadism or start TRT from a single blood test. Following Endocrine Society and military guidelines, require at least two consecutive, fasting, early-morning blood draws below the threshold (accompanied by clinical symptoms), and ensure you have not undergone severe sleep restriction or a harsh caloric deficit in the preceding 30 days.
• Demand Gold-Standard Laboratory Assays: When ordering hormone panels, specify Liquid Chromatography-Mass Spectrometry (LC-MS) for Total Testosterone, Equilibrium Dialysis for Free Testosterone (avoiding calculated Vermeulen equations), and Ultrasensitive Estradiol via LC-MS (avoiding standard immunoassays).
• Treat Low Testosterone as a Metabolic or Lifestyle Canary: Before considering lifelong exogenous hormones, screen for the ~120 underlying causes of suppression—specifically targeting visceral/liver fat if overweight, chronic under-eating if lean, sleep apnea, micronutrient deficiencies (zinc, magnesium, copper), medications (opioids, SSRIs), pituitary adenomas, constrictive cycling seats, and testicular varicoceles (especially if you do heavy Valsalva lifting).
• Target Metabolic Syndrome to Prevent "Andropause": To maintain youthful testosterone levels into your 70s, focus on eliminating all markers of metabolic syndrome: keep your waist circumference under half your height (waist-to-height ratio <0.5) and maintain healthy blood pressure, HbA1c, triglycerides, and HDL.
• Do Not Fear High SHBG If You Are Lean and Active: If your Total Testosterone is healthy (e.g., 650 ng/dL) but your SHBG is flagged as "high" (40 to 60 nmol/L), recognize that this reflects low liver fat and high insulin sensitivity—or a current caloric deficit—rather than a disease requiring TRT.
• Refeed Properly to Recover Diet-Suppressed Hormones: If extreme dieting, rapid massive weight loss, or low body fat has tanked your leptin and testosterone (and spiked SHBG), implement a structured refeed: set dietary fat to at least 80 g/day for men and 50 to 60 g/day for women (>20% of calories or ~0.8 g/kg), and stair-step whole-food carbohydrates up by 25 to 50 g/day each week while expecting an initial 4 to 6 lb gain in gut mass, glycogen, and water.
• Stop Blaming Eugonadal Testosterone for Poor Gym Progress: If your Total Testosterone is anywhere within the normal physiological range (300 to 1,000+ ng/dL), stop trying to micro-optimize hormone fluctuations to build muscle; focus instead on resistance training volume, progressive overload, sleep, and adequate calorie intake.
• Use Low-Impact Movement for Recovery: Incorporate ~8,000 steps per day or low-level aerobic stationary bike work to promote blood flow and recovery without adding mechanical court or field impact.
• Monitor Hematocrit and Cardiac Markers Rigorously on TRT: If you use exogenous testosterone, run a Complete Blood Count (CBC with differential, ~$5.50) regularly to ensure hematocrit never exceeds 52% (and treat 54% or higher as an immediate medical red flag), alongside routine checks of blood pressure, lipids (HDL), PSA, ultrasensitive estradiol, and an ECG/cardiac stress test to screen for atrial fibrillation and left ventricular hypertrophy.
• Target Conservative Physiological Levels on TRT: If clinically indicated for TRT, follow modern military guidelines by targeting a conservative peak Total Testosterone of 600 to 700 ng/dL (reducing your dose if levels exceed this) rather than running supraphysiological "TRT+" protocols at 1,000 to 1,500 ng/dL.
• Never Quit Exogenous Testosterone Cold Turkey: Because exogenous testosterone shuts down endogenous LH/FSH production and atrophies the testes (unless managed with HCG), never abruptly stop TRT without medical supervision and a transition protocol, as sudden withdrawal carries severe risks of clinical psychosis and suicidality.